Faris Lee Investments is pleased to present the exclusive opportunity to acquire an Investment Grade single-tenant net-leased offering occupied by Fresenius Kidney Care (BBB- rated / NYSE: FMS) in Sacramento, California. As an international leader in renal care with a $12.16+ billion market cap and over 4,000 locations globally, Fresenius provides an institutionalgrade, recession-resilient credit investment. The offering is secured by an original 15-year lease with 11 years of primary term remaining, featuring 1.5% annual rent escalations that ensure consistent cash-flow growth and a strong hedge against inflation. This location is a significant commitment by Fresenius, evidenced by their strategic relocation to the site and a massive $7 million tenant-funded capital investment. The facility was custom-built to support a state-of-the-art 48-station dialysis clinic, complete with extensive infrastructure upgrades including a new roof and building systems. Offered with minimal landlord management obligations, the asset features a streamlined structure where the tenant reimburses 100% of its pro-rata CAM expenses, providing a highly passive vehicle for institutional or private capital seeking secure yield. Strategically located in close proximity to Kaiser Permanente South Sacramento MedicalCenter with over 780,000 sqft on 48.5 acres. Situated at the focal point of a major retail and medical hub, the asset benefits from exceptional surrounding synergies. The property is co-anchored within a thriving center featuring a soon to open H-Mart, DD’s Discounts, Starbucks, McDonald’s, and AutoZone. The site enjoys superior visibility along Mack Road with nearly (42,300 VPD) at the intersection immediately accessible to Highway 99 (170,800 VPD). The site is surrounded by high-volume national retailers including Costco, Target, and Lowe’s, and is supported by a robust demographic base of over 380,000 residents within a 5-mile radius.